GALECTIN THERAPEUTICS INC. Accrued Liabilities, Current
GALECTIN THERAPEUTICS INC. (GALT) had Accrued Liabilities, Current of $3.99 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $3.99M.
- 2026-03-31: Accrued Liabilities, Current $4.19M.
- 2025-12-31: Accrued Liabilities, Current $4.72M.
- 2025-09-30: Accrued Liabilities, Current $5.04M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $3.99M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.19M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.72M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $5.04M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $4.85M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $6.89M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.20M 10-K · filed 2026-03-31 |
| 2024-09-30 | $11.59M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $10.86M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $8.84M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $9.18M 10-K · filed 2025-03-31 |
| 2023-09-30 | $7.84M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.91M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.98M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.06M 10-K · filed 2024-03-29 |
| 2022-09-30 | $7.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.86M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.63M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.16M 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.38M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.07M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.28M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.04M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $4.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $656.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.09M 10-K · filed 2021-03-31 |
| 2019-09-30 | $862.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $857.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $459.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.51M 10-K · filed 2020-03-16 |
| 2018-09-30 | $1.48M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.15M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.13M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.29M 10-K · filed 2019-03-06 |
| 2017-09-30 | $4.17M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.04M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $3.02M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.80M 10-K · filed 2018-03-29 |
| 2016-09-30 | $3.44M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $2.64M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.94M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $845.00K 10-K · filed 2017-03-28 |
| 2015-09-30 | $797.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.06M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $369.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $729.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $542.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.41M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.45M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $1.65M 10-K · filed 2015-03-18 |
| 2013-09-30 | $1.23M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.13M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.15M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.16M 10-K · filed 2014-03-21 |
| 2012-09-30 | $1.19M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $1.25M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $1.27M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $1.55M 10-K · filed 2013-03-29 |
| 2011-09-30 | $417.00K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $376.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $537.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |